Can Wegovy Cause Diarrhoea? A Practical Guide to What Happens and Why

Diarrhoea is a recognised, commonly reported side effect of semaglutide (Wegovy); it appears on the NHS's own medicines page for semaglutide.
It tends to peak when you first start or after each dose step, then ease as your body adjusts — usually within a week or two.
Severe or persistent diarrhoea can lead to dehydration; knowing the signs that warrant medical help is a core part of safe treatment.
Suspected side effects (including unexpected or severe gut symptoms) can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Yes, Wegovy can cause diarrhoea. It is one of the more commonly reported gastrointestinal side effects of semaglutide, the active ingredient in Wegovy, and it typically appears in the early weeks of treatment or after a dose increase. For most people it is mild and settles on its own. Understanding the pattern helps you tell normal adjustment from something that needs attention — and that distinction matters for staying safe on a prescription medicine. Wegovy is a prescription-only treatment for weight management in adults; a clinician assesses suitability before it is prescribed, and side-effect questions are part of that conversation.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How diarrhoea fits into Wegovy's side-effect picture, and what to do about it

Step 1: Recognise the pattern, when diarrhoea is most likely to appear

Wegovy slows the rate at which food moves through your stomach and alters gut hormone signalling. Both effects help reduce appetite, but they also change the environment your digestive system is used to. The result, for many people, is a period of loose or more frequent stools, particularly in the first few days after starting treatment or after each upward dose step.

The NHS medicines page for semaglutide lists diarrhoea as a common side effect, meaning it affects somewhere between one in ten and one in a hundred people. In clinical trials it was reported more often in the first weeks and generally reduced as the weeks passed. The key word is transient. Loose stools that arrive on day three of a new dose and are gone by day ten sit squarely within the expected adjustment window.

A quick checking habit worth building: note roughly when a new dose starts and keep a loose mental log of gut symptoms for the first fortnight. You do not need a spreadsheet, just a sense of whether things are improving week on week. If they are, you are almost certainly in normal territory. If they are not, read on. You can also find a broader overview of Wegovy's full side-effect profile if you want the wider picture alongside what to prioritise.

Nausea, constipation, burping and reflux tend to travel with diarrhoea as part of the same GI cluster. Not everyone gets all of them; some people get none. The dose titration schedule exists partly to keep these effects manageable, which is one reason prescribers move carefully and do not jump straight to higher doses.

Step 2: Understand the mechanism, why Wegovy causes diarrhoea specifically

GLP-1 receptor agonists like semaglutide act on receptors throughout the gut, not just in the brain. Slowed gastric emptying changes the timing and composition of what arrives in the small intestine. Bile acid secretion patterns shift. Gut motility (the rhythmic contractions that move contents along) can become less predictable during the adaptation phase. The collective effect can tip some people toward loose stools rather than constipation, while others experience the opposite. Biology varies.

There is a more detailed look at the mechanics behind this if you want it, including how the drug's action on gut receptors differs from its effect on appetite centres, the page on why Wegovy causes diarrhoea goes into more depth on the physiology without requiring a science background.

Practically, this means diet choices interact with how strongly the symptom presents. High-fat meals, very spicy food and alcohol can all intensify gut reactions during the early weeks. Smaller portions, lower-fat meals and adequate hydration tend to reduce the severity. These are not rigid rules, they are things patients often discover by trial and error, and your prescriber or the patient information leaflet can help tailor this to your situation.

Semaglutide is also the active ingredient in Ozempic and Rybelsus, though those products are licensed for type 2 diabetes rather than weight management. The mechanism driving GI side effects is shared, so the broader picture of whether semaglutide causes diarrhoea covers evidence across the semaglutide family if that context is useful.

Step 3: Know when diarrhoea crosses from normal to a reason to get medical help

Most diarrhoea on Wegovy does not need a GP call. Diarrhoea that is severe, that lasts more than a few days without improvement, or that is accompanied by signs of dehydration is different. Signs of dehydration to watch for include feeling very thirsty, passing dark urine, dizziness when you stand up, and a dry mouth. Persistent vomiting alongside diarrhoea accelerates fluid loss quickly.

The MHRA's January 2026 Drug Safety Update for GLP-1 medicines highlighted acute pancreatitis as an infrequent but serious risk: the warning sign is severe, persistent abdominal pain that may extend into the back, sometimes with vomiting. That symptom pattern is different from ordinary loose stools, but it is worth knowing because it requires urgent medical attention rather than waiting to see whether it settles. If you experience that kind of pain, stop and seek help promptly.

Kidney function can also be affected if the body becomes significantly dehydrated through prolonged GI illness, another reason not to let severe symptoms run on without speaking to a clinician. The MHRA Yellow Card scheme allows patients to report unexpected or severe side effects directly; doing so contributes to the ongoing safety monitoring of medicines like Wegovy and is something you can do in a few minutes online.

For a focused look at managing loose stools specifically, including practical steps for reducing severity, the Wegovy diarrhoea page covers that ground in detail. And if your symptoms have been particularly disruptive, the page on Wegovy making people feel sick addresses the broader question of when GI reactions prompt a review of whether to continue.

Does the experience differ between people, and what affects how bad it gets?

Yes, noticeably. Some people on Wegovy report no diarrhoea at all. Others find it disruptive for a week or two at each new dose level and then have no further trouble. A smaller group finds it persistent enough to discuss with their prescriber, who may consider slowing the titration schedule, adjusting dietary guidance, or reviewing whether a different approach suits them better.

Factors that seem to influence severity include how quickly the dose is increased, individual gut sensitivity, baseline diet composition, and whether the person is also taking other medicines that affect gut motility. There is no reliable way to predict in advance how any individual will respond, which is one reason ongoing prescriber review matters rather than a one-and-done assessment.

If you are thinking about Wegovy and wondering how to weigh its side-effect profile against the clinical evidence for weight loss, the Wegovy overview brings those threads together. Our prescribers at nume discuss side effects as a routine part of the consultation, what to expect, what to watch for, and how to get support if something concerns you. Wegovy is a prescription-only medicine, and clinical assessment is the starting point; if you are ready to take that step, start your free consultation and speak to our prescribers about whether it is right for you.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions